Entia is a medical technology company that specializes in improving access to blood test.
Entia has raised $20.7M in total funding. The most recent round was Series A. The last funding was announced in July 2023.
Entia's investors include Business Growth Fund, Innovate UK, Parkwalk Advisors, Sussex Place Ventures, Microsoft Accelerator London.
Entia is headquartered in London, United Kingdom.
Entia is a medical technology company that specializes in improving access to blood test.
Entia is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Entia — Funding & Investors." VCBacked, July 26, 2023, https://www.vcbacked.co/company/entia. Accessed July 20, 2026.
VCBacked. (2023). Entia — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/entia
{{cite web |title=Entia — Funding & Investors |url=https://www.vcbacked.co/company/entia |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated